These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28890897)

  • 1. Corrigendum to "Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis".
    Cao Y; Wang J; Zhang H; Tian Q; Chen L; Ning S; Liu P; Sun X; Lu X; Song C; Zhang S; Xiao B; Wang L
    Biomed Res Int; 2017; 2017():9281250. PubMed ID: 28890897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting key genes regulated by miRNAs in dysfunctional crosstalk pathway of myasthenia gravis.
    Cao Y; Wang J; Zhang H; Tian Q; Chen L; Ning S; Liu P; Sun X; Lu X; Song C; Zhang S; Xiao B; Wang L
    Biomed Res Int; 2015; 2015():724715. PubMed ID: 25705681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on "Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis".
    Le Panse R
    Biomed Res Int; 2017; 2017():6950308. PubMed ID: 28271070
    [No Abstract]   [Full Text] [Related]  

  • 4. Response to: Comment on "Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis".
    Cao Y; Wang J; Zhang H; Tian Q; Chen L; Ning S; Liu P; Sun X; Lu X; Song C; Zhang S; Xiao B; Wang L
    Biomed Res Int; 2017; 2017():5359434. PubMed ID: 28884124
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum: Leflunomide combined with low-dose prednisone inhibits proinflammatory T cells responses in myasthenia gravis patients.
    Huang X; Ran H; Li Y; Ma Q; Ou C; Qiu L; Feng H; Liu W
    Front Neurol; 2023; 14():1179017. PubMed ID: 37006501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Gender and Ethnicity Based Differences in Clinical and Laboratory Features of Myasthenia Gravis".
    Abukhalil F; Sultan AA; Mehta B; Saito E; Mehta S; McMurtray A
    Autoimmune Dis; 2021; 2021():9862946. PubMed ID: 34194823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corrigendum to "Safety and effectiveness of eculizumab in Japanese patients with generalized myasthenia gravis: interim analysis of post-marketing surveillance".
    Ther Adv Neurol Disord; 2021; 14():17562864211049696. PubMed ID: 34733355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional chemosensation in myasthenia gravis: a systematic review.
    Leon-Sarmiento FE; Leon-Ariza DS; Doty RL
    J Clin Neuromuscul Dis; 2013 Sep; 15(1):1-6. PubMed ID: 23965402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting dysfunctional crosstalk pathways regulated by miRNAs during glioma progression.
    Zhang Y; Xu Y; Li F; Li X; Feng L; Shi X; Wang L; Li X
    Oncotarget; 2016 May; 7(18):25769-82. PubMed ID: 27013589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis.
    Cao Y; Lu X; Wang J; Zhang H; Liu Z; Xu S; Wang T; Ning S; Xiao B; Wang L
    Int J Mol Med; 2017 Feb; 39(2):268-278. PubMed ID: 28075449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of diagnostic tests in myasthenia gravis.
    Nicholson GA; McLeod JG; Griffiths LR
    Clin Exp Neurol; 1983; 19():45-9. PubMed ID: 6568927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on myasthenia gravis.
    Thanvi BR; Lo TC
    Postgrad Med J; 2004 Dec; 80(950):690-700. PubMed ID: 15579606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of Epstein-Barr virus infection in Chinese myasthenia gravis patients.
    Jing F; Wei D; Wang D; Li N; Cui F; Yang F; Chen Z; Huang X
    Acta Neurol Scand; 2013 Nov; 128(5):345-50. PubMed ID: 23668247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Myasthenia gravis seronegative for acetylcholine receptor antibodies in South Korea: Autoantibody profiles and clinical features.
    Park KH; Waters P; Woodhall M; Lang B; Smith T; Sung JJ; Kim KK; Lim YM; Kim JE; Kim BJ; Park JS; Lim JG; Kim DS; Kwon O; Sohn EH; Bae JS; Yoon BN; Kim NH; Ahn SW; Oh J; Park HJ; Shin KJ; Hong YH
    PLoS One; 2018; 13(6):e0200225. PubMed ID: 29958297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of HLA-DQA1*0101/2 and DQB1*0502 with myasthenia gravis in southern Iranian patients.
    Yousefipour GA; Salami Z; Farjadian S
    Iran J Immunol; 2009 Jun; 6(2):99-102. PubMed ID: 19561379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dental management of patients with myasthenia gravis: a literature review.
    Yarom N; Barnea E; Nissan J; Gorsky M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Aug; 100(2):158-63. PubMed ID: 16037773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation.
    Le Panse R; Berrih-Aknin S
    Curr Opin Neurol; 2013 Oct; 26(5):569-76. PubMed ID: 23995274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptors 7 and 9 in myasthenia gravis thymus: amplifiers of autoimmunity?
    Cavalcante P; Barzago C; Baggi F; Antozzi C; Maggi L; Mantegazza R; Bernasconi P
    Ann N Y Acad Sci; 2018 Feb; 1413(1):11-24. PubMed ID: 29363775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune mechanisms in myasthenia gravis.
    Cavalcante P; Bernasconi P; Mantegazza R
    Curr Opin Neurol; 2012 Oct; 25(5):621-9. PubMed ID: 22941261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An increase in circulating B cell-activating factor in childhood-onset ocular myasthenia gravis.
    Motobayashi M; Inaba Y; Nishimura T; Kobayashi N; Nakazawa Y; Koike K
    Pediatr Neurol; 2015 Apr; 52(4):404-9. PubMed ID: 25661289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.